Wegovy is now the first weight loss medication to also be approved to help prevent life-threatening cardiovascular events in adults with cardiovascular disease and either obesity or overweight, John Sharretts, M.D., director of the Division of Diabetes, Lipid Disorders, and Obesity in the FDAs Center for Drug Evaluation and Research, said in a statement
(7) The observations suggest that by the conclusion of the third week, wounds exposed to dressings containing biotinylated GHK (a tripeptide with skin regenerative properties) nearly achieved full closure, registering at 99.39%
Your PlexusDx provider can document your pre-pause weight, restart response, and long-term trajectory to show that pausing does not derail ultimate success
This article examines the potential role of tirzepatide in patients with Hashimoto's thyroiditis, explores the evidence for benefits and risks, and outlines alternative evidence-based approaches to weight management in this population
